| Date | Form | Description | Docs | XBRL | Pages |
| 09/01/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
20 |
| 06/10/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
23 |
| 03/11/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 09/08/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 06/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
60 |
| 03/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 09/06/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
84 |
| 06/12/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 03/13/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 09/07/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
33 |
Latest News & Events
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
Read More...